Ascent Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.85M | Sell |
45,148
-4,794
| -10% | -$515K | 0.19% | 113 |
|
|
2025
Q1 | $5.04M | Buy |
49,942
+34,645
| +226% | +$3.49M | 0.22% | 101 |
|
|
2024
Q4 | $1.37M | Buy |
15,297
+7,009
| +85% | +$626K | 0.1% | 237 |
|
|
2024
Q3 | $695K | Buy |
8,288
+808
| +11% | +$67.7K | 0.05% | 331 |
|
|
2024
Q2 | $576K | Buy |
7,480
+790
| +12% | +$60.8K | 0.05% | 336 |
|
|
2024
Q1 | $458K | Sell |
6,690
-72
| -1% | -$4.93K | 0.04% | 373 |
|
|
2023
Q4 | $439K | Buy |
6,762
+303
| +5% | +$19.7K | 0.04% | 367 |
|
|
2023
Q3 | $332K | Buy |
6,459
+541
| +9% | +$27.8K | 0.04% | 371 |
|
|
2023
Q2 | $299K | Sell |
5,918
-310
| -5% | -$15.7K | 0.03% | 375 |
|
|
2023
Q1 | $312K | Buy |
+6,228
| New | +$312K | 0.03% | 396 |
|